Targeting glioma cells by antineoplastic activity of reversine

Gliomas are the most common type of primary central nervous system tumors and despite great advances in understanding the molecular basis of the disease very few new therapies have been developed. Reversine, a synthetic purine analog, is a multikinase inhibitor that targets aurora kinase A (AURKA) a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncol Lett
Päätekijät: Hirakata, Camila, Lima, Keli, De Almeida, Bruna Oliveira, De Miranda, Lívia Bassani Lins, Florêncio, Katharine Gurgel Dias, Furtado, Luciana Costa, Costa-Lotufo, Leticia Veras, Machado-Neto, João Agostinho
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: D.A. Spandidos 2021
Aiheet:
Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC8227489/
https://ncbi.nlm.nih.gov/pubmed/34188712
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2021.12871
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia